Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Oncologists Seek Immediate Fixes To Medicare Part B Payment Rates

Executive Summary

The American Society of Clinical Oncology is seeking legislation to create an "exceptions" process to ensure that Medicare Part B drug payments to oncologists cover drug acquisition costs

You may also be interested in...



Oncology Reimbursement May Be Addressed In Tax Bill This Year

The American Society of Clinical Oncology hopes that a tax bill this fall will be a vehicle for changing the Medicare Part B payment rate for cancer medicines in 2005

Oncology Reimbursement May Be Addressed In Tax Bill This Year

The American Society of Clinical Oncology hopes that a tax bill this fall will be a vehicle for changing the Medicare Part B payment rate for cancer medicines in 2005

Medicare Competitive Bidding Savings For Single-Source Drugs Questioned

Competitive bidding for Medicare Part B drugs may not result in sufficient savings for certain single-source drugs, an AstraZeneca attorney told the Centers for Medicare & Medicaid Services April 20

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043403

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel